Timo Burster
Laboratory: C4, 610
Email: timo.burster@nu.edu.kz
1. Research
1. 1. The cooperation between proteases and host cells is pivotal in mounting an effective innate immune response. Such an immune response is initiated, in particular, by neutrophils releasing granules containing serine proteases, including neutrophil elastase (NE), cathepsin G (CatG), protease 3 (PR3), and neutrophil serine protease 4 (NSP4), collectively classified as neutrophil serine proteases (NSPs). Functional responsibilities of NSPs, specifically bivalent regulation of major histocompatibility complex class I (MHC) molecules, underscore a novel role of NSPs within the immune system. Furthermore, we are interested in generating and applying novel activity-based probes for activity-based protein profiling using Western blot, SDS-PAGE, fluorescence microscopy, and flow cytometry to detect proteolytic active serine protease and test novel serine protease inhibitors. The additional part of the research includes antigen processing of the S protein of SARS-CoV-2 and their novel variants and subvariants. Finally, several proteome profiler arrays were established in the laboratory in order to determine protease as well as protease inhibitors.
1.2. The synergistic interaction of CatG with the human alveolar basal epithelial cell line is of particular interest due to its potential implications against viral infection. Our study aimed to investigate the binding capacity of CatG on the surface of such cells. CatG shows proteolytic activity to fortify target cells against viral entrance.
1.3. Perspectives: Investigating the regulation of mediators in asymptomatic- and symptomatic patients as well as individuals with long COVID-19.
2. Selected publications:
2.1. Zhadyra Mustafa, Hubert Kalbacher, and Timo Burster. Occurrence of a novel cleavage site for cathepsin G adjacent to the polybasic sequence within the proteolytically sensitive activation loop of the SARS-CoV-2 Omicron variant: The amino acid substitution N679K and P681H of the spike protein. 2022. PlosOne. 10.1371/journal.pone.0264723. IF: 3.752. SJR: 0.85, Q1
2.2. Akmaral Assylbekova, Anuar Zhanapiya, Renata Grzywa, Marcin Sienczyk, Christian Schönbach and Timo Burster. Camostat Does Not Inhibit the Proteolytic Activity of Neutrophil Serine Proteases. 2022. Pharmaceuticals. IF: 5.215. SJR: 0.85, Q1
2.3. Nadine Schilling, Hubert Kalbacher, Timo Burster. Variation of proteolytic cleavage sites towards the N-terminal end of the S2 subunit of the novel SARS-CoV-2 Omicron sublineage BA.2.12.1. 2022. Molecules. IF: 4.927. SJR: 0.71, Q1